New semisynthetic α-glucosidase inhibitor from a doubly-chemically engineered extract

Area of Science:

• Medicinal Chemistry
• Natural Product Chemistry
• Enzyme Inhibition

Background:

• Chemically engineered extracts offer novel semi-synthetic bioactive molecules.
• Derivatization of natural products can introduce unique elements and substructures.
• Natural products are a rich source for drug discovery and development.

Purpose of the Study:

• To investigate the α-glucosidase inhibition properties of chemically engineered natural extracts.
• To identify and characterize novel bioactive compounds derived from natural sources.
• To explore the impact of chemical modifications on the bioactivity of natural products.

Main Methods:

• Preparation of fourteen chemically engineered extracts via sequential reactions with hydrazine and a fluorinating reagent.
• Comparison of α-glucosidase inhibition properties of the prepared extracts.
• Bio-guided fractionation to isolate the most potent inhibitor.
• Chemical characterization of the isolated compound.

Main Results:

• A chemically modified propolis extract exhibited a 22-fold increase in α-glucosidase inhibition.
• Isolation of a new fluorinated pyrazole from the propolis extract.
• The isolated inhibitor resulted from the chemical transformation of the flavonoid chrysin.
• The inhibitor demonstrated an approximately 20-fold increase in α-glucosidase inhibition compared to its natural precursor.

Conclusions:

• Chemical engineering of natural extracts is a viable strategy for discovering potent bioactive molecules.
• The novel fluorinated pyrazole is a highly effective α-glucosidase inhibitor.
• Specific chemical transformations, including heterocycle opening, dehydroxylation, and fluorination, enhance bioactivity.